MarketCap
Facebook
X
TelegramGeschäftsbericht 2025
hinzugefügt 25.02.2026
Alkermes plc P/B 2011-2026 | ALKS
P/B Jährlich Alkermes plc
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2.82 | 3.79 | 4.06 | 4.42 | 3.36 | 2.97 | 2.53 | 4.34 | 7.31 | 6.55 | 3.63 | 7.51 | 4.41 | 2.32 | 3.52 |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 7.51 | 2.32 | 4.24 |
P/B anderer Aktien in der Pharmaeinzelhändler
| Name | P/B | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
MorphoSys AG
MOR
|
1.28 | - | 2.43 % | $ 254 M |  Germany |
 |
AbCellera Biologics
ABCL
|
0.995 | $ 3.55 | -0.28 % | $ 1.06 B |  Canada |
 |
Acorda Therapeutics
ACOR
|
0.154 | - | -24.86 % | $ 820 K |  USA |
 |
Acasti Pharma
ACST
|
0.612 | - | 4.01 % | $ 150 M | Canada |
 |
Advaxis
ADXS
|
0.113 | - | -9.65 % | $ 45.9 M | USA |
 |
AC Immune SA
ACIU
|
1.32 | $ 3.25 | 3.67 % | $ 229 M |  Schweiz |
 |
I-Mab
IMAB
|
1.12 | - | - | $ 866 M |  China |
 |
Aeglea BioTherapeutics
AGLE
|
1.4 | - | - | $ 1.01 B | USA |
 |
AgeX Therapeutics
AGE
|
0.00262 | - | -10.17 % | $ 12.2 K | USA |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
2.88 | - | - | $ 40.3 B | USA |
 |
Biophytis SA
BPTS
|
15.7 | - | -13.47 % | $ 169 M |  France |
 |
Albireo Pharma
ALBO
|
3.06 | - | -0.23 % | $ 916 M | USA |
 |
Aileron Therapeutics
ALRN
|
0.702 | - | 10.36 % | $ 9.8 M | USA |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
4.13 | - | -1.52 % | $ 24.7 M | USA |
 |
ADC Therapeutics SA
ADCT
|
7.34 | $ 4.14 | -1.9 % | $ 105 M | Schweiz |
 |
Aptorum Group Limited
APM
|
0.347 | $ 0.79 | - | $ 4.31 M | China |
 |
Midatech Pharma plc
MTP
|
7.56 | - | -18.52 % | $ 27.3 M |  Britain |
 |
Arcturus Therapeutics Holdings
ARCT
|
1.01 | $ 6.58 | -0.75 % | $ 180 M |  Israel |
 |
argenx SE
ARGX
|
5.43 | $ 710.26 | 0.99 % | $ 25 B |  Niderland |
 |
Adverum Biotechnologies
ADVM
|
1.08 | - | - | $ 86.2 M | USA |
 |
Alterity Therapeutics Limited
ATHE
|
125 | $ 3.43 | -4.99 % | $ 8.25 B |  Australia |
 |
Ascendis Pharma A/S
ASND
|
8.34 | $ 229.93 | -0.47 % | $ 5 B |  Danmark |
 |
Applied Genetic Technologies Corporation
AGTC
|
0.382 | - | - | $ 26.5 M | USA |
 |
Applied Molecular Transport
AMTI
|
0.364 | - | - | $ 10.1 M | USA |
 |
Atea Pharmaceuticals
AVIR
|
1.55 | $ 6.09 | 0.58 % | $ 496 M | USA |
 |
BioCardia
BCDA
|
-5.55 | $ 1.31 | 2.91 % | $ 27.7 M | USA |
 |
Институт стволовых клеток человека
ISKJ
|
6.81 | - | - | - |  Russia |
 |
Akero Therapeutics
AKRO
|
4.34 | - | - | $ 3.67 B | USA |
 |
Athersys
ATHX
|
11.6 | - | 3.77 % | $ 22.4 M | USA |
 |
Akouos
AKUS
|
0.736 | - | 0.23 % | $ 488 M | USA |
 |
Acer Therapeutics
ACER
|
-0.724 | - | 2.71 % | $ 14 M | USA |
 |
ARCA biopharma
ABIO
|
1.27 | - | 1052.0 % | $ 415 M | USA |
 |
Allena Pharmaceuticals
ALNA
|
3.16 | - | 3.16 % | $ 1.9 M | USA |
 |
Aeterna Zentaris
AEZS
|
0.781 | - | 5.93 % | $ 314 M | Canada |
 |
AlloVir
ALVR
|
0.432 | - | 4.14 % | $ 49.1 M | USA |
 |
Can-Fite BioPharma Ltd.
CANF
|
32 | $ 3.47 | -3.07 % | $ 7.55 B | Israel |
 |
Catalyst Biosciences
CBIO
|
7.02 | $ 11.19 | -3.41 % | $ 1 B | USA |
 |
Anika Therapeutics
ANIK
|
1.38 | $ 14.61 | 1.74 % | $ 214 M | USA |
 |
Aptinyx
APTX
|
0.248 | - | -39.0 % | $ 4.57 M | USA |
 |
Aptose Biosciences
APTO
|
-0.511 | - | -45.71 % | $ 1.2 M | Canada |
 |
AVEO Pharmaceuticals
AVEO
|
2.14 | - | - | $ 521 M | USA |
 |
Ayala Pharmaceuticals
AYLA
|
0.994 | - | - | $ 7.46 M | Israel |
 |
CNS Pharmaceuticals
CNSP
|
0.0842 | $ 2.36 | -3.55 % | $ 902 K | USA |
 |
Aytu BioScience
AYTU
|
0.127 | $ 2.62 | -0.75 % | $ 16.5 M | USA |
 |
Avenue Therapeutics
ATXI
|
0.293 | - | -52.27 % | $ 4.45 M | USA |
 |
Autolus Therapeutics plc
AUTL
|
0.991 | $ 1.51 | - | $ 385 M | Britain |
 |
BioNTech SE
BNTX
|
5.29 | $ 93.66 | 3.45 % | $ 27.2 B | Germany |
 |
Athira Pharma
ATHA
|
0.36 | - | - | $ 269 M | USA |
 |
CureVac N.V.
CVAC
|
5.13 | - | - | $ 867 M | Germany |
 |
Aravive
ARAV
|
5.67 | - | -13.39 % | $ 1.45 M | USA |